ANTB Recent News AntriaBio to Present at 16th Ann
Post# of 8
AntriaBio to Present at 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 Marketwire - Wed Feb 05, 7:05AM CST
AntriaBio Inc concludes bridge financing to advance AB101 into clinical development for the treatment of diabetes M2 - Fri Jan 17, 4:46AM CST
AntriaBio Announces Closing of Bridge Financing Marketwire - Thu Jan 16, 9:07AM CST
AntriaBio Granted European Patent Allowance for Method of Preparing Site-Specific Protein Conjugates Marketwire - Wed Jul 24, 7:30AM CDT
AntriaBio Initiates Effort to Raise up to $12 Million in a Private Placement Marketwire - Mon Jul 01, 7:31AM CDT
AntriaBio Set for a Major Short Squeeze Marketwire - Thu Mar 14, 10:50AM CDT
Once-a-Week Insulin Shot Could Help Growing Diabetes Patient Base and Spell Huge Profits for Investors Marketwire - Fri Feb 22, 6:23AM CST
AntriaBio Appoints Two Industry Leaders to Its Management Team Marketwire - Tue Feb 19, 9:38AM CST
AntriaBio Announces Stock Ticker Symbol Change to ANTB Marketwire - Fri Feb 08, 9:45AM CST